Tacita Capital Inc Bausch Health Companies Inc. Transaction History

Tacita Capital Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Aug 12, 2022	SELL	$7.06 - $23.63 $13,696 - $45,842	-1,940 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$21.6 - $27.79 $3,240 - $4,168	150 Added 8.38%	1,940 $44,000
Q3 2021 Nov 08, 2021	BUY	$25.04 - $30.06 $4,757 - $5,711	190 Added 11.88%	1,790 $50,000
Q2 2021 Aug 12, 2021	BUY	$27.43 - $32.7 $6,857 - $8,175	250 Added 18.52%	1,600 $47,000
Q1 2021 May 14, 2021	BUY	$21.37 - $34.38 $28,849 - $46,413	1,350 New	1,350 $43,000

271

252M

5.12M

9.43M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.53B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Tacita Capital Inc, based on Form 13F filings with the SEC.

Stay updated on Tacita Capital Inc with notifications on news.